Shandong Realcan Pharmaceutical Co Ltd

002589 · SHE · Healthcare / Medical Distribution

2.76CNY-0.08 (-2.82%)

Price History

Full chart

Market Stats

Previous Close2.84

Open2.84

Day Range2.75 – 2.85

52-Week Range2.38 – 4.69

Volume47.60M

Market Cap4.92B

P/E (TTM)327.00

Forward P/E30.96

EPS0.01

Dividend Yield0.06%

Beta0.23

50-Day Avg3.14

200-Day Avg3.13

About

Realcan Pharmaceutical Group Co., Ltd. sells medicines, medical devices, and medical consumables to medical institutions in China. It operates through the Drug and Equipment Distribution, In Vitro Diagnostics, Pharmaceutical Logistics, Traditional Chinese Medicine, and Microbiome Medicine segments. The company engages in the processing, manufacture, sale, and wholesale of Chinese medicinal materials, herbal medicine, and patent medicine. It is also involved in the wholesale of biochemical, psychotropic, narcotic, and toxic drugs for medical use; chemical APIs, and preparations; antibiotics, biological products, anabolic steroids, peptide hormones, and pharmaceutical precursor chemicals; and medical devices. In addition, the company provides leasing of medical devices and technical services; investment management and consulting services; medical sterilization outsourcing and consulting services; health consulting services; and pharmaceutical logistics services. Further, it engages in the warehousing and distribution of drugs; technology development and transfer; and operation of a health service platform. The company was formerly known as Realcan Pharmaceutical Co., Ltd. and changed its name to Realcan Pharmaceutical Group Co., Ltd. in December 2018. Realcan Pharmaceutical Group Co., Ltd. was founded in 2004 and is based in Yantai, China.

Company Details

SectorHealthcare
IndustryMedical Distribution
CEOMr. Xu Han
Employees2.41K
HeadquartersBuilding 13, Yantai, China, 264001, China
Websitehttps://www.realcan.cn

Leadership

Mr. Xu HanPresident & Chairman · b. 1965
Ms. Yi FengCFO & VP · b. 1970
Mr. Bo YangVP & Director · b. 1983
Mr. Zhe LiVP, Secretary & Director · b. 1986
Qing Yan CaoAccounting Supervisor

Financials

Income Statement

Currency: CNY	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	1.15B	1.60B	2.21B	3.20B	4.62B	5.93B	7.79B	9.75B	15.62B	23.29B	33.92B	35.26B	27.23B	21.06B	12.31B	8.03B	7.97B	7.30B
Growth (%)	-	+39.63%	+38.19%	+44.37%	+44.65%	+28.20%	+31.39%	+25.23%	+60.19%	+49.14%	+45.61%	+3.95%	-22.76%	-22.67%	-41.54%	-34.74%	-0.85%	-8.42%
Cost of Revenue	1.05B	1.46B	2.03B	2.93B	4.25B	5.42B	7.08B	8.69B	13.20B	19.09B	27.54B	28.60B	22.37B	17.31B	10.68B	7.21B	7.10B	6.52B
Gross Profit	101.64M	137.64M	183.75M	261.76M	376.19M	508.00M	701.16M	1.06B	2.42B	4.21B	6.38B	6.66B	4.86B	3.74B	1.63B	822.06M	870.74M	776.06M
Gross Margin	8.86%	8.59%	8.30%	8.19%	8.14%	8.57%	9.01%	10.89%	15.47%	18.06%	18.80%	18.89%	17.84%	17.78%	13.22%	10.23%	10.93%	10.64%
Operating Expense	62.00M	74.75M	98.61M	148.21M	187.31M	312.70M	465.39M	752.68M	1.55B	2.40B	4.40B	6.53B	3.90B	3.25B	3.34B	948.70M	845.21M	707.89M
Operating Income	39.64M	62.89M	85.14M	113.56M	188.88M	195.31M	235.77M	308.94M	861.33M	1.81B	1.97B	129.72M	955.55M	499.08M	-1.72B	-126.64M	25.53M	68.16M
Operating Margin	3.46%	3.93%	3.85%	3.55%	4.09%	3.30%	3.03%	3.17%	5.51%	7.77%	5.82%	0.37%	3.51%	2.37%	-13.94%	-1.58%	0.32%	0.93%
EBITDA	48.54M	73.89M	101.96M	142.42M	194.29M	273.97M	346.64M	450.69M	1.06B	2.23B	2.95B	1.29B	1.92B	1.36B	-1.02B	403.11M	417.92M	360.68M
EBITDA Margin	4.23%	4.61%	4.61%	4.46%	4.20%	4.62%	4.45%	4.62%	6.80%	9.55%	8.69%	3.66%	7.04%	6.48%	-8.31%	5.02%	5.25%	4.94%
Net Income	29.18M	44.76M	62.11M	84.06M	110.65M	143.55M	180.99M	235.94M	590.76M	1.01B	771.18M	-927.80M	261.30M	131.18M	-1.83B	20.32M	20.62M	16.07M
Net Income Margin	2.54%	2.79%	2.81%	2.63%	2.39%	2.42%	2.32%	2.42%	3.78%	4.33%	2.27%	-2.63%	0.96%	0.62%	-14.87%	0.25%	0.26%	0.22%
R&D	-	-	-	-	-	-	-	-	-	1.34M	-	6.97M	8.91M	11.56M	22.68M	14.61M	34.94M	20.91M
R&D as % of Total Revenue	-	-	-	-	-	-	-	-	-	0.01%	-	0.02%	0.03%	0.05%	0.18%	0.18%	0.44%	0.29%
Interest Expense	7.22M	10.06M	14.19M	23.77M	38.55M	68.67M	80.39M	89.11M	105.20M	268.06M	762.24M	913.06M	709.31M	599.81M	446.09M	323.35M	214.77M	178.86M
Interest Expense % of Total Revenue	0.63%	0.63%	0.64%	0.74%	0.83%	1.16%	1.03%	0.91%	0.67%	1.15%	2.25%	2.59%	2.60%	2.85%	3.62%	4.02%	2.70%	2.45%

Balance Sheet

Currency: CNY	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	715.53M	1.04B	1.48B	2.22B	3.12B	4.45B	5.68B	8.86B	15.66B	26.98B	34.84B	32.47B	31.29B	26.40B	18.33B	16.71B	16.01B	14.37B
Total Liabilities	603.64M	805.78M	1.18B	1.40B	2.20B	2.80B	3.85B	5.46B	8.15B	17.31B	23.53B	22.21B	21.65B	16.70B	12.58B	11.07B	10.32B	8.95B
Total Equity	111.89M	233.92M	296.03M	815.18M	916.41M	1.63B	1.80B	3.19B	6.88B	7.81B	8.45B	7.19B	7.47B	7.57B	5.41B	5.45B	5.54B	5.30B
Cash	80.08M	255.96M	349.68M	307.27M	398.10M	648.07M	578.52M	1.18B	2.05B	2.02B	3.07B	4.83B	5.73B	4.58B	5.34B	5.06B	4.98B	3.74B
Total Debt	110.00M	180.00M	256.07M	317.50M	640.00M	912.71M	1.27B	1.58B	1.92B	5.33B	8.62B	6.57B	10.06B	4.27B	3.92B	6.82B	6.42B	-
Net Debt	29.92M	-75.96M	-93.61M	10.23M	241.90M	264.64M	694.23M	406.17M	-127.05M	3.31B	4.55B	1.74B	3.79B	-309.63M	-1.42B	1.76B	1.44B	690.68M

Cash Flow

Currency: CNY	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	-49.88M	61.38M	70.56M	-475.03M	-170.52M	-274.46M	-163.62M	-466.26M	-1.76B	-2.42B	-201.66M	2.09B	414.96M	442.95M	523.07M	82.47M	160.44M	13.76M
Investing Cash Flow	-30.87M	-20.89M	-37.98M	-45.38M	-117.29M	-170.88M	-201.85M	-400.31M	-638.63M	-772.76M	-1.59B	-1.32B	-944.04M	-583.51M	592.96M	579.53M	203.98M	-
Financing Cash Flow	88.97M	62.96M	32.32M	541.87M	388.67M	747.94M	277.46M	1.35B	3.23B	2.96B	2.31B	-268.00M	-1.08B	-50.42M	-1.47B	-677.20M	-146.47M	-
Capital Expenditure	30.96M	19.23M	37.72M	28.60M	112.25M	153.10M	183.25M	109.47M	317.30M	385.20M	604.32M	934.87M	505.39M	461.09M	170.96M	298.38M	111.53M	26.82M
Free Cash Flow	-80.83M	42.15M	32.84M	-503.63M	-282.77M	-427.56M	-346.87M	-575.73M	-2.08B	-2.81B	-773.73M	1.16B	-140.85M	-18.13M	352.11M	-215.92M	48.92M	-13.06M
Dividends Paid	5.92M	9.37M	12.07M	18.96M	44.06M	70.58M	83.19M	93.25M	114.31M	224.33M	516.06M	499.64M	346.56M	316.31M	13.27M	201.69M	198.71M	174.50M
FCF to OCF	162.07%	68.67%	46.54%	106.02%	165.83%	155.78%	212.00%	123.48%	118.04%	115.90%	383.68%	55.37%	-33.94%	-4.09%	67.32%	-261.82%	30.49%	-94.93%
Dividend Paid to FCF	-7.32%	22.23%	36.75%	-3.77%	-15.58%	-16.51%	-23.98%	-16.20%	-5.51%	-7.99%	-66.70%	43.09%	-246.04%	-1744.40%	3.77%	-93.41%	406.22%	-1335.99%

Earnings

Report Date	Aug 31, 2011	Nov 30, 2011	Feb 29, 2012	Apr 24, 2012	Jul 31, 2012	Oct 25, 2012	Jan 27, 2013	Apr 24, 2013	Jul 28, 2013	Oct 27, 2013	Feb 13, 2014	Apr 23, 2014	Jul 24, 2014	Oct 21, 2014	Feb 26, 2015	Apr 21, 2015	Aug 28, 2015	Oct 25, 2015	Feb 29, 2016	Apr 27, 2016	Aug 30, 2016	Oct 26, 2016	Jan 25, 2017	Apr 25, 2017	Aug 27, 2017	Oct 30, 2017	Jan 31, 2018	Apr 25, 2018	Jul 30, 2018	Oct 29, 2018	Feb 28, 2019	Apr 29, 2019	Aug 28, 2019	Oct 30, 2019	Feb 21, 2020	Apr 29, 2020	Aug 27, 2020	Oct 30, 2020	Apr 30, 2021	Aug 27, 2021	Nov 1, 2021	Apr 30, 2022	Aug 25, 2022	Oct 31, 2022	Apr 29, 2023	Aug 30, 2023	Oct 31, 2023	May 21, 2024	Aug 27, 2024	Oct 31, 2024	Apr 24, 2025	Jun 30, 2025	Sep 30, 2025	Dec 31, 2025	Mar 31, 2026	Jun 30, 2026
EPS Estimate	-	-	-	0.03	0.03	0.04	0.04	0.03	0.05	0.05	0.04	0.04	0.04	0.05	0.06	0.05	0.06	0.07	0.07	0.06	0.11	0.08	0.11	0.10	0.13	0.14	0.20	0.18	0.20	0.22	0.25	0.25	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EPS Actual	0.05	0.03	0.04	0.03	0.03	0.04	0.04	0.04	0.04	0.05	0.05	0.04	0.03	0.05	0.04	0.05	0.04	0.05	0.06	0.07	0.10	0.11	0.18	0.19	0.15	0.12	0.19	0.19	0.20	0.17	-0.04	-0.03	0.13	0.13	-1.00	-1.02	0.08	0.07	-0.03	0.02	0.01	0.03	0.01	0.00	0.01	0.01	-0.01	0.00	0.01	0.01	-0.01	0.00	-0.00	0.00	0.01	0.00
Surprise	-	-	-	0.00%	0.00%	0.00%	0.00%	33.33%	-20.00%	0.00%	25.00%	0.00%	-25.00%	0.00%	-33.33%	0.00%	-33.33%	-28.57%	-14.29%	16.67%	-9.09%	37.50%	63.64%	90.00%	15.38%	-14.29%	-5.00%	5.56%	0.00%	-22.73%	-116.00%	-112.00%	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Timing	-	-	-	After-hours	After-hours	Pre-market	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	Pre-market	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	Pre-market	Pre-market	After-hours	After-hours	After-hours	-	-	-	Pre-market	-	-	-	-	-	After-hours	-	-	-	-	-	-	-	-

Key Statistics & Ratios

Market Cap4.92B

Enterprise Value4.51B

Trailing P/E327.00

Forward P/E30.96

PEG Ratio0.00

Price / Sales0.69

Price / Book0.96

EPS0.01

Book Value3.61

Revenue (TTM)7.17B

Gross Profit (TTM)781.40M

EBITDA261.43M

Profit Margin0.13%

Operating Margin1.52%

Return on Equity0.79%

Return on Assets0.52%

Shares Outstanding1.50B

Shares Float1.04B

Beta0.23

Dividend Yield0.06%

Dividend Rate0.00

Payout Ratio32.26%

Dividends

20261×

0.00Jun 30, 2026

20251×

0.00Jul 8, 2025

20242×

0.01Nov 29, 20240.01Jun 4, 2024

20221×

0.01Jul 22, 2022

20211×

0.02Jun 23, 2021

20191×

0.05Jun 27, 2019

20181×

0.07Jul 18, 2018

20171×

0.04May 15, 2017

20161×

0.02May 19, 2016

20151×

0.01Jul 9, 2015

20141×

0.01Jul 14, 2014

20131×

0.01May 22, 2013

20121×

0.01May 29, 2012

Stock Splits

May 15, 201723:10
Sep 23, 201520:10
Jul 14, 201420:10